Delivery Order SPE2DB22D3004-SPE2DB25FRH84
Award Date
7/7/25
Potential Completion Date
7/8/25
Potential Value
$7.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $31,397.94 firm fixed-price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 10, 2025 with a completion date of June 11, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This federal contract award is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML pharmaceuticals to the Defense Logistics Agency (DLA), a defense agency. The $14,848.16 firm fixed price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 2, 2025 with an ultimate completion date of July 3, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
This federal contract award is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $7,806.33 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of October 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025, which...
This federal contract award is for the delivery of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML medical products to the Defense Logistics Agency (DLA), a defense agency. The $14,369.41 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract has a completion date of June 23, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $3,375.02, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
The federal contract award is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a firm fixed price of $4,575.48. The contract is a delivery order with a performance period through May 21, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of ZEPBOUND 12.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The $1,105.65 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 11, 2024. The contract has an ultimate completion date of October 15, 2024 and is not designated with a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA...
This federal contract award is for the delivery of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $3,488.64 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 28, 2024 with a completion date of October 29, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical...
This federal contract award is for the delivery of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $2,097.77 firm-fixed-price delivery order contract was awarded on June 5, 2025 to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a completion date of June 6, 2025. This order is not a set-aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract...
This federal contract award is for the delivery of ZEPBOUND 15 MG/0.5 ML PEN 0.5ML medical products. The $9,237.05 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of July 14, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...